logo of the EU drugs agency

You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.

Table TDI-11. Age at first use distributions and primary drug distributions — EU summary of clients entering treatment, 2008 or most recent year available [see all tables in this series...]

Part (iv) All outpatient clients, primary drug distribution by age at first use (%)

Substance<1515–1920–2425–2930–3435–3940–4445+Age knownAge not known
Opiates23.246.660.458.956.652.748.947.78984116815
Cocaine13.021.427.131.333.133.834.226.0439503811
Stimulants3.24.52.72.11.91.41.51.563321151
Hypnotics and sedatives0.80.81.01.82.94.87.510.62482761
Hallucinogens0.30.30.30.40.71.33.09.7837168
Volatile substances0.30.10.10.00.20.00.40.1260181
Cannabis 58.225.87.95.14.04.03.02.9431306755
Other substances 0.90.50.40.30.72.01.51.511051247
Total30548788764214518486907548622367157818793730889

Notes:

 Countries reporting data: BE, BG, CZ, DK, DE,EE, IE, EL, ES, FR, IT, CY, LV, HU, MT, NL, AT, RO, SI, SK, FI, SE, HR 

 Last data available from Spain refer to 2007, for Malta refer to 2006 and for Belgium refer to 2005. 

 The number of treatment clients in each country is listed in Table TDI-7

 See also Table TDI-107 on distribution by country and '‘General notes for interpreting data'’ on the Explanatory notes and help page

Sources:

 Reitox national reports 2009 — Table TDI — outpatient treatment centres. 

(see the help page for information about formats etc.)

Page last updated: Wednesday, 14 July 2010